A Bull's Eye for Targeted Lung Cancer Therapy
作者： John D Minna , Adi F Gazdar , Stephen R Sprang , Joachim Herz
关键词:
摘要: The tyrosine kinase inhibitor gefitinib has had mixed results in the treatment of lung cancer. reason is now revealed two papers published here ( Paez et al.) and elsewhere, which receive in-depth discussion a Perspective by Minna al. new studies show that tumors from subset cancer patients with an efficacious response to carry mutations domain EGF receptor. findings should enable early selection those most likely respond well gefitinib.
sciencemag.org
elsevier.com参考文章(6)
Fortunato Ciardiello, Ferdinando De Vita, Michele Orditura, Giampaolo Tortora, The role of EGFR inhibitors in nonsmall cell lung cancer. Current Opinion in Oncology. ,vol. 16, pp. 130- 135 ,(2004) , 10.1097/00001622-200403000-00008
Jyoti D. Patel, Peter B. Bach, Mark G. Kris, Lung Cancer in US Women: A Contemporary Epidemic JAMA. ,vol. 291, pp. 1763- 1768 ,(2004) , 10.1001/JAMA.291.14.1763
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938
Brian J. Druker, STI571 (Gleevec™) as a paradigm for cancer therapy Trends in Molecular Medicine. ,vol. 8, pp. S14- S18 ,(2002) , 10.1016/S1471-4914(02)02305-5
C. David James, Greg Eley, Xiao Yang Wang, Lori Frederick, Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Research. ,vol. 60, pp. 1383- 1387 ,(2000)
J Guillermo Paez, Pasi A Janne, Jeffrey C Lee, Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J Kaye, Neal Lindeman, Titus J Boggon, Katsuhiko Naoki, Hidefumi Sasaki, Yoshitaka Fujii, Michael J Eck, William R Sellers, Bruce E Johnson, Matthew Meyerson, EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. ,vol. 304, pp. 1497- 1500 ,(2004) , 10.1126/SCIENCE.1099314